Bolodeoku, J., T. Gbaa, K. Morris, and S. Whitehead. “Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and Evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/L LDL Cholesterol Target in a Secondary Care Lipid Clinic”. British Journal of Healthcare and Medical Research, vol. 10, no. 6, Dec. 2023, pp. 91-102, doi:10.14738/bjhmr.106.15955.